Collection

Services and information

MHRA services & information for patients and healthcare professionals.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 29 March 2023

Blood regulation and safety

• Medical devices: how to comply with the legal requirements in Great Britain
  • 31 December 2020
  • Guidance
• MHRA fees
  • 20 November 2023
  • Statutory guidance
• Blood: authorisations and safety reporting
  • 24 February 2021
  • Guidance
• Make a payment to MHRA
  • 21 December 2023
  • Guidance

Clinical trials and investigations

• Clinical trials for medicines: apply for authorisation in the UK
  • 10 April 2024
  • Guidance
• Clinical trials for medicines: manage your authorisation, report safety issues
  • 26 March 2024
  • Guidance
• Notify MHRA about a clinical investigation for a medical device
  • 23 April 2024
  • Guidance
• MHRA phase I accreditation scheme
  • 10 November 2023
  • Guidance

Conferences and events

• Conferences and events
  • 27 June 2023
  • Collection
• Request a MHRA speaker at an event or conference
  • 13 October 2014
  • Guidance

Good practice, inspections and enforcement

• Good manufacturing practice and good distribution practice
  • 27 December 2020
  • Guidance
• Good clinical practice for clinical trials
  • 6 April 2023
  • Guidance
• MHRA phase I accreditation scheme
  • 10 November 2023
  • Guidance
• MHRA fees
  • 20 November 2023
  • Statutory guidance

Herbal and homeopathic medicines

• MHRA fees
  • 20 November 2023
  • Statutory guidance
• Apply for a traditional herbal registration (THR)
  • 5 January 2024
  • Guidance
• Make a payment to MHRA
  • 21 December 2023
  • Guidance
• List of banned or restricted herbal ingredients for medicinal use
  • 18 December 2014
  • Guidance

Licensing

• Medicines: reclassify your product
  • 10 April 2024
  • Guidance

Manufacturing, wholesaling, importing and exporting medicines

• Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
  • 15 April 2024
  • Decision
• Good manufacturing practice and good distribution practice
  • 27 December 2020
  • Guidance
• Medicines: reclassify your product
  • 10 April 2024
  • Guidance
• Medicines that you cannot export from the UK or hoard
  • 24 April 2024
  • Guidance

Marketing authorisations, variations and licensing guidance

• Apply for a licence to market a medicine in the UK
  • 22 April 2024
  • Guidance
• Medicines: reclassify your product
  • 10 April 2024
  • Guidance
• Medicines: packaging, labelling and patient information leaflets
  • 7 March 2024
  • Guidance
• Project Orbis
  • 12 January 2024
  • Guidance

Medical devices regulation and safety

• Alerts, recalls and safety information: drugs and medical devices
  • 11 December 2023
• Regulating medical devices in the UK
  • 8 February 2024
  • Guidance
• Register medical devices to place on the market
  • 11 January 2024
  • Guidance
• Medical devices: guidance for manufacturers on vigilance
  • 3 August 2023
  • Collection

Vigilance, safety alerts and guidance

• Alerts, recalls and safety information: drugs and medical devices
  • 11 December 2023
• Drug Safety Update
  • 11 December 2023
• Coronavirus (COVID-19) vaccines adverse reactions
  • 8 March 2023
  • Research and analysis
• Medical devices: guidance for manufacturers on vigilance
  • 3 August 2023
  • Collection

Published 29 March 2023